Eli Lilly refused injunction against Teva, Actavis and Mylan
17-11-2017
Eli Lilly defeated as Cialis patent found obvious on appeal
01-11-2017
rs-photo / iStockphoto.com
Eli Lilly appears to be mulling whether to oppose a trademark registered by Bristol-Myers Squibb (BMS) at the US Patent and Trademark Office.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
BMS, Eli Lilly, TTAB, USPTO, Trademark Trial and Appeal Board, trademark opposition, trademark
